1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Clinical indicators independently associated with good acute leptomeningeal collateral flow in patients with cardioembolic stroke on multivariate analysis
OR 95% CI P Value Female sex 0.81 0.21–2.87 .74 Age (for 1-year increase) 1.03 0.99–1.09 .14 NIHSS score on admission (for 1-point increase) 0.95 0.86–1.04 .26 Blood glucose level (for 1-mmol/L increase) 0.87 0.64–1.13 .30 Reduced leukoaraiosis (total Fazekas scores of 0–2) 5.79 1.40–29.61 .01 Thrombus length (for 1-mm increase) 0.91 0.82–0.99 .04